Medecision Appoints Mark Gee as Chief Revenue Officer to Spearhead Growth and Innovation
DALLAS and KING OF PRUSSIA, Pa., Feb. 26, 2024 /PRNewswire/ -- Medecision, the leading clinical data and analytics platform company,...
DALLAS and KING OF PRUSSIA, Pa., Feb. 26, 2024 /PRNewswire/ -- Medecision, the leading clinical data and analytics platform company,...
RADNOR, Pa. and LISBON, Portugal, Feb. 26, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical...
Introducing Felipe Díaz-Arango, A Seasoned Strategist Ready to Propel PACO Collective to New Heights CHICAGO, Feb. 26, 2024 /PRNewswire/ --...
New Guided VCTE™ technology will increase efficiency, automation and standardization to make liver scanning seamless for all healthcare providers WALTHAM,...
Collaboration supports the patient journey across the care continuum and eases transitions and care from the hospital to home CHICAGO...
DUBLIN, Feb. 26, 2024 /PRNewswire/ -- The "Paternity & Relationship Testing Services. Global Market Forecasts for Applications and Technologies with...
Allows Research and Developers to Extract Insights from Imaging and Notes with Natural Language Text PromptsPALO ALTO, CA / ACCESSWIRE...
Unanimously Recommended by Special Committee of the Agiliti Board of Directors Agiliti Shareholders to Receive $10.00 per Share in Cash,...
Enhancements will help seniors get real-time access to local in-network providersLOUISVILLE, Ky. & MADISON, Wis.--(BUSINESS WIRE)--Leading health and well-being company...
Houston, Texas--(Newsfile Corp. - February 26, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is excited to announce that...
TORONTO, ON / ACCESSWIRE / February 26, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...
MALVERN, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused...
JERUSALEM, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the...
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on...
Oak Ridge, TN, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement...
ARLINGTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research,...
A total of 19 patients with serious/life-threatening invasive fungal infections have been enrolled, including aspergillosis, mucormycosis, fusarium, candidiasis, cryptococcosis, and...
BURLINGAME, Calif.--(BUSINESS WIRE)--#AI--Mednition, a Silicon Valley leader in clinical artificial intelligence (AI) healthcare solutions, is excited to announce the appointment...
Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous...
SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first...